In celebration of Children’s Health Month, Preceptis Medical has chosen AcuityMD’s AI platform to enhance the market reach of its Hummingbird® Tympanostomy Tube System (TTS). This innovative device allows pediatric ear tube placement in-office, eliminating the need for an operating room and general anesthesia. David Carey, CEO of Preceptis Medical, emphasized the company’s focus on growth and the necessity for a robust technology platform to facilitate smarter, faster decision-making. The Hummingbird TTS has shown strong early market adoption, prompting further expansion efforts. The device provides a simpler, preferred option for ear tube procedures, typically performed in an operating room, which can be costly and risky. Dr. Shelagh A. Cofer from the Mayo Clinic praised the Hummingbird TTS as a ‘single-pass’ tool, highlighting its efficiency in office settings. AcuityMD plays a crucial role in Preceptis Medical’s Hummingbird Catalyst program, aimed at increasing awareness and access to the device among surgeons, payers, pediatricians, and parents. AcuityMD’s platform, trusted by over 400 MedTech companies, combines healthcare data with AI insights to accelerate the adoption of medical technology.
previous post
next post

